Electrostatic driven transport enhances penetration of positively charged peptide surfaces through tumor extracellular matrix
Source abstract
Abstract
Drug carriers achieve poor and heterogeneous distribution within solid tumors due to limited transport through the tumor extracellular matrix (ECM). The tumor ECM forms a net negatively charged network that interacts with and hinders the transport of molecules in part due to electrostatic interactions. Traditionally, the surfaces of drug delivery systems are passivated to minimize these interactions, but the mechanism of how charge interactions impact transport and penetration within the tumor microenvironment (TME) is not well understood. Here, we used T7 bacteriophage as a model biological nanoparticle to display peptides of different charges on its surface and elucidate how charge-based binding drives transport, uptake, and retention within tumor tissue. In contrast to current studies with neutrally charged surfaces, we discovered that a positively charged peptide displayed on T7 enhanced its penetration through a tumor-like ECM when compared to neutrally and negatively charged peptides. The positively charged peptide displayed on T7 facilitated weak and reversible binding with the TME to achieve Donnan partitioning and deep penetration into ex vivo tumor tissue. Additionally, the positively charged peptide-presenting T7 has a high number of intra-tissue binding sites in the TME (~4 µM) that enables almost 100% retention in the tumor tissue for up to 24 h. These results, coupled with transport studies of systematically mutated T7, show that electrostatic interactions can be responsible for uptake and retention of the positively charged peptide-presenting T7 within the net negatively charged TME. STATEMENT OF SIGNIFICANCE: The TME selectively hinders the transport of drugs and drug delivery systems due to their size, shape, and intermolecular interactions. Typically, the focus in drug delivery has been to develop delivery systems smaller than the pore size of the tumor ECM and/or develop inert surface coatings that have negligible interactions with the tumor ECM for diffusive transport. While there is an association of the surface charge of carriers with their transport through the tumor ECM, the mechanism of charge-driven transport is poorly understood. In this work, we elucidate the mechanism and find that interestingly, particles with a weakly positive surface charge interact with the net negatively charged tumor ECM to significantly improve their uptake, penetration, and retention in tumor tissue.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanopore and Nanochannel Transport Studies · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (63)
Show source-provided references
1. Drug resistance and the solid tumor microenvironment10.1093/jnci/djm135 ↗
2. Drug penetration in solid tumours10.1038/nrc1893 ↗
3. Strategies for advancing cancer nanomedicine10.1038/nmat3792 ↗
4. Multichannel imaging to quantify four classes of pharmacokinetic distribution in tumors10.1002/jps.24086 ↗
5. Direct visualization of heterogeneous extravascular distribution of trastuzumab in human epidermal growth factor receptor type 2 overexpressing xenografts10.1158/1078-0432.CCR-07-4465 ↗
6. Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy
7. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner10.1038/nnano.2012.45 ↗
8. Tailoring nanoparticle designs to target cancer based on tumor pathophysiology10.1073/pnas.1521265113 ↗
9. Accumulation of sub-100nm polymeric micelles in poorly permeable tumours depends on size10.1038/nnano.2011.166 ↗
10. Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies10.1146/annurev-chembioeng-061010-114300 ↗
11. Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: from Mathematical Modeling to Bench to Bedside10.1016/j.trecan.2018.02.005 ↗
12. Selective filtering of particles by the extracellular matrix: an electrostatic bandpass10.1016/j.bpj.2009.07.009 ↗
13. Drug-Induced Self-Assembly of Modified Albumins as Nano-theranostics for Tumor-Targeted Combination Therapy10.1021/acsnano.5b00640 ↗
14. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment10.1073/pnas.95.8.4607 ↗
15. Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo10.1021/nn301282m ↗
16. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid)10.1016/j.actbio.2015.10.017 ↗
17. Synthesis and surface modification of highly monodispersed, spherical gold nanoparticles of 50-200nm10.1021/ja907069u ↗
18. A nanoparticle size series for in vivo fluorescence imaging10.1002/anie.201003142 ↗
19. Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release10.1016/j.biomaterials.2015.05.006 ↗
20. Photoswitchable nanoparticles for in vivo cancer chemotherapy10.1073/pnas.1315336110 ↗
21. Photoswitchable nanoparticles for triggered tissue penetration and drug delivery10.1021/ja211888a ↗
22. Multistage nanoparticle delivery system for deep penetration into tumor tissue10.1073/pnas.1018382108 ↗
23. Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration10.1002/anie.201104449 ↗
24. Mediating tumor targeting efficiency of nanoparticles through design10.1021/nl900031y ↗
25. The impact of aspect ratio on the biodistribution and tumor homing of rigid soft-matter nanorods10.1002/adhm.201400641 ↗
26. intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation10.1021/nl204175t ↗
27. Comparison study of gold nanohexapods, nanorods, and nanocages for photothermal cancer treatment10.1021/nn304332s ↗
28. Non-specific binding and steric hindrance thresholds for penetration of particulate drug carriers within tumor tissue10.1016/j.jconrel.2016.07.034 ↗
29. Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood-brain barrier using MRI-guided focused ultrasound10.1016/j.jconrel.2014.06.031 ↗
30. Brain-penetrating nanoparticles improve paclitaxel efficacy in malignant glioma following local administration10.1021/nn504210g ↗
31. A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue10.1126/scitranslmed.3003594 ↗
32. Surface chemistry-mediated penetration and gold nanorod thermotherapy in multicellular tumor spheroids10.1039/C2NR31877F ↗
33. Surface charge critically affects tumor penetration and therapeutic efficacy of cancer nanomedicines10.1016/j.nantod.2016.04.008 ↗
34. Sustained intra-cartilage delivery of low dose dexamethasone using a cationic carrier for treatment of post traumatic osteoarthritis10.22203/eCM.v034a21 ↗
35. Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis10.1016/j.biomaterials.2013.09.091 ↗
36. Cartilage penetrating cationic peptide carriers for applications in drug delivery to avascular negatively charged tissues10.1016/j.actbio.2018.12.004 ↗
37. The particle in the spider's web: transport through biological hydrogels10.1039/C6NR09736G ↗
38. The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin10.1111/1462-2920.12155 ↗
39. Spatial configuration and composition of charge modulates transport into a mucin hydrogel barrier10.1016/j.bpj.2013.07.050 ↗
40. Transport and binding of insulin-like growth factor I through articular cartilage10.1016/S0003-9861(03)00215-7 ↗
41. Cartilage-penetrating nanocarriers improve delivery and efficacy of growth factor treatment of osteoarthritis10.1126/scitranslmed.aat8800 ↗
42. Cartilage-targeting drug delivery: can electrostatic interactions help?10.1038/nrrheum.2016.210 ↗
43. Grodzinsky · 2011 · xii
44. Identification of peptide coatings that enhance diffusive transport of nanoparticles through the tumor microenvironment10.1039/C9NR05783H ↗
45. Diffusion and convection in collagen gels: implications for transport in the tumor interstitium10.1016/S0006-3495(02)73933-7 ↗
46. Multiscale measurements distinguish cellular and interstitial hindrances to diffusion in vivo10.1016/j.bpj.2009.03.064 ↗
47. Interstitial pressure in pancreatic ductal adenocarcinoma is dominated by a gel-fluid phase10.1016/j.bpj.2016.03.040 ↗
48. Role of extracellular matrix assembly in interstitial transport in solid tumors
49. A spectrophotometer-based diffusivity assay reveals that diffusion hindrance of small molecules in extracellular matrix gels used in 3D cultures is dominated by viscous effects10.1016/j.colsurfb.2014.05.017 ↗
50. Use of fluorescently labeled phage in the detection and identification of bacterial species10.1366/00037020360696008 ↗
51. Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity10.1016/j.addr.2015.01.002 ↗
52. progress, challenges and opportunities10.1038/nrc.2016.108 ↗
53. The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors10.1158/1078-0432.CCR-05-1664 ↗
54. Transport of molecules, particles, and cells in solid tumors10.1146/annurev.bioeng.1.1.241 ↗
55. Design considerations for nanotherapeutics in oncology10.1016/j.nano.2015.07.015 ↗
56. Influence of PEGylation on nanoparticle mobility in different models of the extracellular matrix10.1016/j.ejpb.2016.08.007 ↗
57. Phage-enabled nanomedicine: from probes to therapeutics in precision medicine10.1002/anie.201606181 ↗
58. Diffusion of particles in the extracellular matrix: the effect of repulsive electrostatic interactions10.1016/j.bpj.2010.06.016 ↗
59. Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer10.1152/physrev.00037.2011 ↗
60. Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors
61. A conductivity approach to measuring fixed charge density in intervertebral disc tissue10.1007/s10439-009-9792-0 ↗
62. Surface charge critically affects tumor penetration and therapeutic efficacy of cancer nanomedicines10.1016/j.nantod.2016.04.008 ↗
63. Peptides as Surface Coatings of Nanoparticles That Penetrate Human Cystic Fibrosis Sputum and Uniformly Distribute in Vivo Following Pulmonary Delivery10.1016/j.jconrel.2020.03.032 ↗